Clinical trial · Interventional
Shared Meditation Involving People With Cancer, Carers and Third Parties
Shared Meditation Involving People With Cancer, Carers and Third Parties: Any Added Value Compared With Meditation Conducted With Patients? IMPLIC 2, a Randomised Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Although the benefits of meditation are increasingly well documented, few hospitals offer this integrative approach in their supportive cancer care. Meditation is sometimes provided, but its potential benefits remain insufficiently evaluated. This project is based on the hypothesis that there could be a benefit in meditating together.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Patients With Cancer | Malignant Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Meditation with patients oly | Behavioral | — | UNRESOLVED |
| Shared meditation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Shared meditation
- description
- Shared" meditation: mixed groups of patients, carers and third parties
- interventionNames
- Behavioral: Shared meditation
- type
- ACTIVE_COMPARATOR
- label
- Meditation "patients"
- description
- groups of patients only
- interventionNames
- Behavioral: Meditation with patients oly
Primary outcomes (1)
- measure
- To assess the possible added value for patients (target population) of a meditation programme shared between patients, carers and third parties, compared with the same meditation programme conducted solely for patients.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Criteria for all participants (patients, carers and third parties) * Participant with no current or previous experience of regular or intensive meditation or comparable practice. Practice is considered regular and/or intensive if : * it occurs more than one day a week for more than 6 consecutive months over the last 10 years, * and/or more than 5 consecutive days of intensive practice (course or retreat) in the last 10 years, * and/or more than 25 consecutive days of retreat (cumulative) in the last 10 years. Patient-specific criteria (target population) - Cancer patients (regardless of location) Specific criteria for carers \- All medical and/or paramedical care staff at the Centre François Baclesse in contact with patients (doctors, nurses, nursing assistants, radiotherapy technicians, etc.) Specific criteria for third parties- Any volunteer not belonging to the two categories above Exclusion Criteria: * Participants with significant vulnerability factors such as alcohol or drug dependence, severe depression, severe social anxiety, recent bereavement, etc.) * Participant unable to undergo trial monitoring for geographical, social or psychopathological reasons
References
Publications (3)
- DERIVEDPrevost V, Christy F, Leconte A, Fernette M, Segura C, Tran T, Clarisse B. Effectiveness of shared meditation involving cancer patients, health professionals and third persons on well-being and psychosocial skills: a randomised study. BMC Complement Med Ther. 2026 Jul 3. doi: 10.1186/s12906-026-05449-5. Online ahead of print. PMID 42399863
- DERIVEDPrevost V, Tran T, Clarisse B, Leconte A, Fernette M, Grandazzi G, Gouriot M. The Experience of Shared Meditation Involving People With Cancer, Health Professionals and Third Persons: A Qualitative Focus-Group Study. Integr Cancer Ther. 2026 Jan-Dec;25:15347354261439128. doi: 10.1177/15347354261439128. Epub 2026 Apr 14. PMID 41979169
- DERIVEDPrevost V, Tran T, Leconte A, Lequesne J, Fernette M, Segura C, Chevigne S, Gouriot M, Clarisse B. A randomised study to evaluate the potential added value of shared meditation involving people with cancer, health professionals and third persons compared to meditation conducted with patients only: design of the Implic-2 protocol. BMC Cancer. 2024 Sep 4;24(1):1097. doi: 10.1186/s12885-024-12521-1. PMID 39232668